Maurizio Bifulco
Overview
Explore the profile of Maurizio Bifulco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
206
Citations
3890
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bifulco M, Di Zazzo E, Affinito A, Pagano C
EMBO Rep
. 2025 Jan;
26(2):303-306.
PMID: 39747667
No abstract available.
2.
Pagano C, Ciaglia E, Coppola L, Lopardo V, Raimondo A, Giuseppe M, et al.
Front Immunol
. 2024 Apr;
15:1373435.
PMID: 38601151
Introduction: The involvement of endocannabinoid system (ECS) in the inflammatory cascade, and the ability of phytocannabinoids, endocannabinoids and their synthetic analogues to modulate it has become an interesting research area...
3.
Pagano C, Coppola L, Navarra G, Avilia G, Savarese B, Torelli G, et al.
FEBS Open Bio
. 2024 Mar;
14(5):843-854.
PMID: 38514913
Glioblastoma (GBM) is a primary tumor in the central nervous system with poor prognosis. It exhibits elevated glucose uptake and lactate production. This metabolic state of aerobic glycolysis is known...
4.
Bruzzaniti S, Piemonte E, Bruzzese D, Lepore M, Strollo R, Izzo L, et al.
Diabetologia
. 2024 Jan;
67(4):714-723.
PMID: 38214712
Aims/hypothesis: Type 1 diabetes is an autoimmune disorder that is characterised by destruction of pancreatic beta cells by autoreactive T lymphocytes. Although islet autoantibodies (AAb) are an indicator of disease...
5.
Di Donato M, Di Zazzo E, Salvati A, Sorrentino C, Giurato G, Fiore D, et al.
J Transl Med
. 2023 Oct;
21(1):736.
PMID: 37853459
Background: Colorectal cancer (CRC) is the third most deadly and fourth most diagnosed cancer worldwide. Despite the progress in early diagnosis and advanced therapeutic options, CRC shows a poor prognosis...
6.
Della Monica R, Buonaiuto M, Cuomo M, Pagano C, Trio F, Costabile D, et al.
Cell Death Dis
. 2023 Sep;
14(9):638.
PMID: 37758718
Despite intense research efforts, glioblastoma remains an incurable brain tumor with a dismal median survival time of 15 months. Thus, identifying new therapeutic targets is an urgent need. Here, we...
7.
Proto M, Fiore D, Bifulco M, Gazzerro P
Int J Mol Sci
. 2023 Sep;
24(17).
PMID: 37686233
The spread of breast cancer to distant sites is the major cause of death in breast cancer patients. Increasing evidence supports the role of the tumor microenvironment (TME) in breast...
8.
9.
Di Zazzo E, Rienzo M, Casamassimi A, De Rosa C, Medici N, Gazzerro P, et al.
J Transl Med
. 2023 Mar;
21(1):217.
PMID: 36964555
Background: T cell activation and programming from their naïve/resting state, characterized by widespread modifications in chromatin accessibility triggering extensive changes in transcriptional programs, is orchestrated by several cytokines and transcription...
10.
Pagano C, Navarra G, Coppola L, Savarese B, Avilia G, Giarra A, et al.
Int J Mol Sci
. 2023 Mar;
24(5).
PMID: 36902485
Pollutants consist of several components, known as direct or indirect mutagens, that can be associated with the risk of tumorigenesis. The increased incidence of brain tumors, observed more frequently in...